Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of 20(S)-ginsenoside-Rg#[3] in the preparing process of medicine for treating or preventing cerebrovascular disease

A cerebrovascular disease and ginsenoside technology, which is applied in the application field of 20(S)-ginsenoside-Rg3 in the preparation of medicines for treating or preventing cerebrovascular diseases

Inactive Publication Date: 2005-03-16
SHANDONG LUYE PHARMA CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But about 20(S)-ginsenoside Rg 3 The utility of preventing or treating cerebrovascular diseases has not been reported yet; the inventor found that 20(S)-ginsenoside Rg 3 Has the use of treating or preventing cerebrovascular diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of 20(S)-ginsenoside-Rg#[3] in the preparing process of medicine for treating or preventing cerebrovascular disease

Examples

Experimental program
Comparison scheme
Effect test

preparation example 1

[0014] Preparation Example 1: 20(S)-Ginsenoside Rg 3 And 20(R)-Ginseng Shake Rg 3 preparation of

[0015] Take total saponins of Panax notoginseng (or total saponins of ginseng) as raw material, add 50% acetic acid aqueous solution, heat in a water bath at 70°C for 6 hours, cool, add 5% sodium carbonate solution, extract the solution with n-butanol, evaporate the extract to dryness, Go up silica gel column, take chloroform-methanol as eluent, carry out gradient elution, obtain 20(S)-ginsenoside Rg 3 and 20(R)-ginsenoside Rg 3 The crude product, through repeated silica gel column chromatography, obtains 20 (S)-ginsenoside Rg respectively 3 and 20(R)-ginsenoside Rg 3 . And according to the literature [Tang Minghui, Jiang Zhihong, Zhao Zhongzhen, et al. Separation and detection of 20(S)-ginsenoside Rg3 and 20(R)-ginsenoside Rg3 by HPLC. Chinese herbal medicine. 2003, 35(3): 208-282.] detection method described above.

preparation example 2

[0016] Preparation Example 2: 20(S)-Ginsenoside Rg for Injection 3 Preparation

[0017] Weigh 0.50g 20(S)-ginsenoside Rg 3 , add 50g PEG-400 to dissolve the saponin; prepare 50g pH5.5 phosphate buffer solution, weigh 0.02g sodium bisulfite and add it to the above phosphate buffer solution; add the buffer solution to the PEG solution of saponin, Mix well, add 0.01% activated carbon for needles and keep warm at 100°C for 30 minutes, G 3 Filtration with a vertically fused glass funnel and a 0.22um microporous membrane. The filtered medicinal solution is packaged into 50 injections of 2ml each.

[0018] Preparation 3: 20(S)-ginsenoside Rg for injection 3 Preparation of freeze-dried powder

[0019] Weigh 0.50g 20(S)-ginsenoside Rg 3 , add 50g PEG-400 to dissolve the saponin. Prepare 50g of pH5.5 phosphate buffer, weigh 0.02g of sodium bisulfite and add it to the above phosphate buffer; add the buffer to the PEG solution of saponin, mix well, add 0.01% activated carbon for nee...

preparation example 4

[0020] Preparation Example 4: 20(R)-Ginsenoside Rg for Injection 3 Preparation

[0021] Weigh 0.50g 20(R)-ginsenoside Rg 3 , add 50g PEG-400 to dissolve the saponin. Prepare 50g of pH5.5 phosphate buffer, weigh 0.02g of sodium bisulfite and add it to the above phosphate buffer; add the buffer to the PEG solution of saponin, mix well, add 0.01% activated carbon for needles, 100°C Keep warm for 30 minutes, G 3 Filtration with a vertically fused glass funnel and a 0.22um microporous membrane; the filtered medicinal solution is divided into 2ml / vials, and freeze-dried by a freeze dryer to make a freeze-dried powder for injection.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an application of 20(S)-ginsenoside-Rg[3] in the preparing process of medicine for treating or preventing cerebrovascular disease. The invention increases the brain blood flow, improves the energy metabolism of the brain mitochondria and improves the blood flow modification.

Description

technical field [0001] The present invention relates to 20(S)-ginsenoside Rg 3 Application in the preparation of medicines for treating or preventing cerebrovascular diseases. Specifically related to 20(S)-ginsenoside Rg 3 Cerebrovascular diseases can be treated or prevented by increasing cerebral blood flow, improving brain mitochondrial energy metabolism, and improving blood rheology. Background technique [0002] With the acceleration of population aging and the change of lifestyle, cerebrovascular disease has become a global health problem, and the death rate of cerebrovascular accidents ranks third in the world, which greatly endangers people's health. The development of new and effective drugs for the prevention and treatment of cerebrovascular diseases is an urgent clinical need. [0003] 20(S)-Ginsenoside Rg 3 It is a tetracyclic triterpenoid panaxadiol saponin monomer isolated from ginseng. [0004] [0005] 20(S)-Ginsenoside Rg 3 Structural formula (R: -gl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/00A61K31/704A61P9/00
Inventor 田京伟傅风华蒋王林王超云
Owner SHANDONG LUYE PHARMA CO LTD